Vasorum USA, Inc. announced FDA approval of the Celt ACD Plus system, which is designed for rapid arterial puncture closure ...
Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug Administration (FDA) approval of the Celt ACD® ...
This next-generation device enhances the proven Celt ACD® platform by providing physicians with a visual indicator for precise placement and closure, particularly beneficial in cases where ...
(MENAFN- PR Newswire) The Celt ACD ® PLUS is an innovative small-bore closure device available in 5F, 6F, and 7F sizes, designed for rapid arterial puncture closure following percutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results